Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Liver Transplantation

  Free Subscription

Articles published in Am J Gastroenterol

Retrieve available abstracts of 31 articles:
HTML format

Single Articles

    October 2021
  1. LIN FP, Visina JM, Bloomer PM, Dunn MA, et al
    Prehabilitation-Driven Changes in Frailty Metrics Predict Mortality in Patients With Advanced Liver Disease.
    Am J Gastroenterol. 2021;116:2105-2117.
    PubMed     Abstract available

    September 2021
  2. SHAH BJ, Onken JE, Edgar L, Jou JH, et al
    Development of gastroenterology and transplant hepatology milestones 2.0: a guide for programs, faculty, and fellows.
    Am J Gastroenterol. 2021 Sep 7. pii: 00000434-990000000-00088.

    July 2021
  3. VAN J, Aloman C, Reau N
    Potential Bias and Misconceptions in Liver Transplantation for Alcohol- and Obesity-Related Liver Disease.
    Am J Gastroenterol. 2021 Jul 1. pii: 00000434-990000000-00032.
    PubMed     Abstract available

    May 2021
  4. FARUQUI S, Okoli FC, Olsen SK, Feldman DM, et al
    Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.
    Am J Gastroenterol. 2021 May 17. pii: 00000434-900000000-98779.
    PubMed     Abstract available

  5. KOH CJ, Koo CS, Doshi BK
    Real-Time 3D Imaging of Post-Transplant Biliary Stricture: A Novel Application of Existing Technology.
    Am J Gastroenterol. 2021 May 14. pii: 00000434-900000000-98777.

  6. JOHN BV, Khakoo NS, Schwartz KB, Aitchenson G, et al
    Ursodeoxycholic Acid Response Is Associated With Reduced Mortality in Primary Biliary Cholangitis With Compensated Cirrhosis.
    Am J Gastroenterol. 2021 May 13. pii: 00000434-900000000-98782.
    PubMed     Abstract available

  7. GOET JC, Murillo Perez CF, Harms MH, Floreani A, et al
    A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis.
    Am J Gastroenterol. 2021 May 4. pii: 00000434-900000000-98792.
    PubMed     Abstract available

  8. CHALASANI NP, Maddur H, Russo MW, Wong RJ, et al
    ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury.
    Am J Gastroenterol. 2021;116:878-898.
    PubMed     Abstract available

    March 2021
  9. JANSSON-KNODELL CL, Calderon G, Weber R, Ghabril M, et al
    Small Intestine Varices in Cirrhosis at a High-Volume Liver Transplant Center: A Retrospective Database Study and Literature Review.
    Am J Gastroenterol. 2021 Mar 10. pii: 00000434-900000000-98858.
    PubMed     Abstract available

  10. VALENTIN N, Guerrido I, Rozenshteyn F, Pinotti R, et al
    Pregnancy Outcomes After Liver Transplantation: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2021;116:491-504.
    PubMed     Abstract available

  11. PARK JS
    Continuing Medical Education Questions: March 2021:Pregnancy Outcomes after Liver Transplantation: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2021;116:457.
    PubMed     Abstract available

    February 2021
  12. TAN HK, Teng MLP, Soh AYS, Cheo SHY, et al
    Poor Outcomes of Cirrhosis due to Nonalcoholic Steatohepatitis Compared With Hepatitis B After Decompensation With Ascites.
    Am J Gastroenterol. 2021 Feb 1. doi: 10.14309/ajg.0000000000001176.
    PubMed     Abstract available

    January 2021
  13. SOBOTKA LA, Mumtaz K, Hinton A, Conteh LF, et al
    Pregnancy in Liver Transplantation Recipients Is Associated With Increased Complications and Healthcare Utilization.
    Am J Gastroenterol. 2021 Jan 20. pii: 00000434-900000000-98936.
    PubMed     Abstract available

    November 2020
  14. ALUKAL JJ, John S, Thuluvath PJ
    Hyponatremia in Cirrhosis: An Update.
    Am J Gastroenterol. 2020;115:1775-1785.
    PubMed     Abstract available

    October 2020
  15. LEE BP, Dodge JL, Terrault NA
    Excess Mortality After Liver Transplantation in Young Women With Alcohol-Associated Liver Disease.
    Am J Gastroenterol. 2020 Oct 28. doi: 10.14309/ajg.0000000000001007.
    PubMed     Abstract available

  16. THULUVATH PJ, To C, Amjad W
    Role of Locoregional Therapies in Patients With Hepatocellular Cancer Awaiting Liver Transplantation.
    Am J Gastroenterol. 2020 Oct 23. doi: 10.14309/ajg.0000000000000999.
    PubMed     Abstract available

  17. OZDOGAN E, Doganay L, Can D, Arikan C, et al
    Disease Course and Treatment Response of Eosinophilic Gastrointestinal Diseases in Children With Liver Transplantation: Long-Term Follow-Up.
    Am J Gastroenterol. 2020 Oct 13. doi: 10.14309/ajg.0000000000000934.
    PubMed     Abstract available

    July 2020
  18. THULUVATH PJ, Bruno DA, Alukal J, Satapathy SK, et al
    Use of HCV-Positive Livers in HCV-Negative Recipients.
    Am J Gastroenterol. 2020;115:1045-1054.
    PubMed     Abstract available

  19. POLANCO NP, Goldberg D
    Transplanting Livers From "HCV-Positive" Donors To HCV-Negative Recipients: Increased Experience But Many Unanswered Questions.
    Am J Gastroenterol. 2020;115:1022-1023.
    PubMed     Abstract available

    June 2020
  20. MANCUSO A, Amata M, Politi F, Mitra M, et al
    Controversies in Budd-Chiari Syndrome Management: Potential Role of Liver Stiffness.
    Am J Gastroenterol. 2020;115:952-953.

    May 2020
  21. REIG A, Norman GL, Garcia M, Shums Z, et al
    Novel Anti-Hexokinase 1 Antibodies Are Associated With Poor Prognosis in Patients With Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 May 27. doi: 10.14309/ajg.0000000000000690.
    PubMed     Abstract available

    March 2020
  22. SALIM TI, Nestlerode LC, Lucatorto EL, Wasserman TL, et al
    Frailty as Tested by Gait Speed Is a Risk Factor for Liver Transplant Respiratory Complications.
    Am J Gastroenterol. 2020 Mar 31. doi: 10.14309/ajg.0000000000000609.
    PubMed     Abstract available

  23. SHAH A, Macdonald GA, Morrison M, Holtmann G, et al
    Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework.
    Am J Gastroenterol. 2020 Mar 25. doi: 10.14309/ajg.0000000000000604.
    PubMed     Abstract available

    January 2020
  24. GORDON SC, Wu KH, Lindor K, Bowlus CL, et al
    Ursodeoxycholic Acid Treatment Preferentially Improves Overall Survival Among African Americans With Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 Jan 27. doi: 10.14309/ajg.0000000000000512.
    PubMed     Abstract available

    November 2019
  25. CAZZAGON N, Lemoinne S, El Mouhadi S, Trivedi PJ, et al
    The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis.
    Am J Gastroenterol. 2019 Nov 14. doi: 10.14309/ajg.0000000000000461.
    PubMed     Abstract available

    The Growing Challenge of Advanced Liver Disease Due to Alcohol Use in the United States.
    Am J Gastroenterol. 2019;114:1712-1713.
    PubMed     Abstract available

    August 2019
  27. GERHARDT F, Benesic A, Tillmann HL, Rademacher S, et al
    Iberogast-Induced Acute Liver Failure-Reexposure and In Vitro Assay Support Causality.
    Am J Gastroenterol. 2019;114:1358-1359.

    July 2019
  28. ALLEGRETTI JR, Kassam Z
    Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: The Next Steps in This Promising Story.
    Am J Gastroenterol. 2019 Jul 10. doi: 10.14309/ajg.0000000000000317.

    June 2019
  29. AHAMED R, Philips CA, Augustine P
    Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis-A Beautiful but Incomplete Story.
    Am J Gastroenterol. 2019 Jun 12. doi: 10.14309/ajg.0000000000000294.

    April 2019
  30. CHEUNG A, Figueredo C, Rinella ME
    Nonalcoholic Fatty Liver Disease: Identification and Management of High-Risk Patients.
    Am J Gastroenterol. 2019;114:579-590.
    PubMed     Abstract available

    July 2018
  31. ADEBAYO D, Neong SF, Wong F
    Refractory Ascites in Liver Cirrhosis.
    Am J Gastroenterol. 2018 Jul 5. pii: 10.1038/s41395-018-0185.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.